Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
recombinant interleukin-11
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized, Double-Blind Study of Daily x 14 Subcutaneous IL-11 vs Placebo for Severe Chemotherapy-Induced Thrombocytopenia (Summary Last Modified 06/98)
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
16 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
GENE-C9504-14
, NCI-V96-0810
2.
Phase III Randomized Study of Interleukin-11 for Chemotherapy-Induced Thrombocytopenia in Patients With Solid Tumors or Lymphoma
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
MRMC-CTCA-9705
, GENE-C9707-14, NCI-V98-1440
3.
Phase II Study of Recombinant Human Interleukin-11 with Sargramostim (GM-CSF) for Acute Myeloid Leukemia Patients Receiving High-Dose Cytarabine During Induction and Consolidation Chemotherapy
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Completed
Age:
18-55
Sponsor:
NCI
Protocol IDs:
E-3997
, E3997
4.
Phase II Study of Interleukin-11 With Filgrastim (G-CSF) in the Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (Summary Last Modified 04/2002)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
FHCRC-1365.00
, NCI-G99-1622, NCT00004157
5.
Interleukin 11, Thrombocytopenia, CML, Imatinib in CML Patients
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2004-0113
, NCT00493181
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute